chr2-27201104-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021095.4(SLC5A6):c.1658G>A(p.Arg553Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00219 in 1,611,090 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_021095.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00208 AC: 317AN: 152056Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.00219 AC: 548AN: 250030Hom.: 3 AF XY: 0.00210 AC XY: 284AN XY: 135056
GnomAD4 exome AF: 0.00220 AC: 3210AN: 1458916Hom.: 7 Cov.: 31 AF XY: 0.00222 AC XY: 1613AN XY: 725796
GnomAD4 genome AF: 0.00208 AC: 317AN: 152174Hom.: 1 Cov.: 31 AF XY: 0.00210 AC XY: 156AN XY: 74400
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 01, 2018 | - - |
Neurodegeneration, infantile-onset, biotin-responsive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 12, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at